Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

F. Vernieri; C. Altamura; C. Aurilia; N. Brunelli; G. Egeo; L. Fofi; C.M. Costa; A. Fallacara; V. Favoni; G. Pierangeli; M. Aguggia; D. Bertuzzo; M. Albanese; P. Di Fiore; F. Frediani; S. Cevoli; P. Barbanti

doi:10.1007/s10072-020-04669-y

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

F. Vernieri, C. Altamura, C. Aurilia, N. Brunelli, G. Egeo, L. Fofi, C.M. Costa, A. Fallacara, V. Favoni, G. Pierangeli, M. Aguggia, D. Bertuzzo, M. Albanese, P. Di Fiore, F. Frediani, S. Cevoli, P. Barbanti

IRCCS San Raffaele Pisana

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	487-488
Number of pages	2
Journal	Neurological Sciences
Volume	41
DOIs	https://doi.org/10.1007/s10072-020-04669-y
Publication status	Published - 2020

Access to Document

10.1007/s10072-020-04669-y

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089870389&doi=10.1007%2fs10072-020-04669-y&partnerID=40&md5=b319c8296204496a63b6fce67137c2dc

Cite this

Vernieri, F., Altamura, C., Aurilia, C., Brunelli, N., Egeo, G., Fofi, L., Costa, C. M., Fallacara, A., Favoni, V., Pierangeli, G., Aguggia, M., Bertuzzo, D., Albanese, M., Di Fiore, P., Frediani, F., Cevoli, S., & Barbanti, P. (2020). Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study). Neurological Sciences, 41, 487-488. https://doi.org/10.1007/s10072-020-04669-y

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study). / Vernieri, F.; Altamura, C.; Aurilia, C.; Brunelli, N.; Egeo, G.; Fofi, L.; Costa, C.M.; Fallacara, A.; Favoni, V.; Pierangeli, G.; Aguggia, M.; Bertuzzo, D.; Albanese, M.; Di Fiore, P.; Frediani, F.; Cevoli, S.; Barbanti, P.

In: Neurological Sciences, Vol. 41, 2020, p. 487-488.

Research output: Contribution to journal › Article › peer-review

Vernieri, F, Altamura, C, Aurilia, C, Brunelli, N, Egeo, G , Fofi, L, Costa, CM, Fallacara, A, Favoni, V, Pierangeli, G, Aguggia, M, Bertuzzo, D, Albanese, M, Di Fiore, P, Frediani, F, Cevoli, S & Barbanti, P 2020, 'Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)', Neurological Sciences, vol. 41, pp. 487-488. https://doi.org/10.1007/s10072-020-04669-y

Vernieri, F. ; Altamura, C. ; Aurilia, C. ; Brunelli, N. ; Egeo, G. ; Fofi, L. ; Costa, C.M. ; Fallacara, A. ; Favoni, V. ; Pierangeli, G. ; Aguggia, M. ; Bertuzzo, D. ; Albanese, M. ; Di Fiore, P. ; Frediani, F. ; Cevoli, S. ; Barbanti, P. / Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study). In: Neurological Sciences. 2020 ; Vol. 41. pp. 487-488.

@article{59d0b7aa9f764ae6925becd95a6e1711,

title = "Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)",

author = "F. Vernieri and C. Altamura and C. Aurilia and N. Brunelli and G. Egeo and L. Fofi and C.M. Costa and A. Fallacara and V. Favoni and G. Pierangeli and M. Aguggia and D. Bertuzzo and M. Albanese and {Di Fiore}, P. and F. Frediani and S. Cevoli and P. Barbanti",

note = "Cited By :1 Export Date: 29 January 2021",

year = "2020",

doi = "10.1007/s10072-020-04669-y",

language = "English",

volume = "41",

pages = "487--488",

journal = "Neurological Sciences",

issn = "1590-1874",

}

TY - JOUR

T1 - Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

AU - Vernieri, F.

AU - Altamura, C.

AU - Aurilia, C.

AU - Brunelli, N.

AU - Egeo, G.

AU - Fofi, L.

AU - Costa, C.M.

AU - Fallacara, A.

AU - Favoni, V.

AU - Pierangeli, G.

AU - Aguggia, M.

AU - Bertuzzo, D.

AU - Albanese, M.

AU - Di Fiore, P.

AU - Frediani, F.

AU - Cevoli, S.

AU - Barbanti, P.

N1 - Cited By :1 Export Date: 29 January 2021

PY - 2020

Y1 - 2020

U2 - 10.1007/s10072-020-04669-y

DO - 10.1007/s10072-020-04669-y

M3 - Article

VL - 41

SP - 487

EP - 488

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

ER -